However, for prostate cancer, the International Union Against Cancer (UICC) proposed in its 7th edition [6] a new classification based on risk or prognostic groups, using not only the T and N components of the stage, but also the histopathological grade or Gleason score and the prostate-specific antigen (PSA) value. This evidence concerns the gene KLK3 and prostate carcinoma.